Drug
Duvakitug
Duvakitug: highest development phase Phase 3, developed by Sanofi. 6 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Duvakitug NCT07185009 | Phase 3 | Ulcerative Colitis |
| Duvakitug NCT07184996 | Phase 3 | Ulcerative Colitis |
| Duvakitug NCT07184944 | Phase 3 | Crohn's Disease |
| Duvakitug NCT07184931 | Phase 3 | Crohn's Disease |
| Duvakitug NCT07812116 | Phase 2 | Hidradenitis |
| Duvakitug NCT07923383 | Phase 1 | Ulcerative Colitis |
Latest
No recent events.
Follow Duvakitug on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.